NCT06099795View on ClinicalTrials.gov

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
SARS-CoV-2 InfectionCOVID-19Coronavirus
Interventions
DEVICE

eBAM Cov Testing

Evaluation of presence/absence of infection with SARS-CoV-2 assessed by eBAM-CoV on air exhaled by the patient compared with the presence/absence of infection based on RT-PCR testing of nasopharyngeal swabs

Trial Locations (2)

13003

NOT_YET_RECRUITING

Laboratoire Alphabio, Hôpital Européen Marseille, Marseille

30029

RECRUITING

CHU de NIMES, Nîmes

All Listed Sponsors
collaborator

University of Nimes

OTHER

collaborator

brains' laboratory sas, FRANCE

UNKNOWN

lead

Centre Hospitalier Universitaire de Nīmes

OTHER